Espen Ajo Arnevik

  • Clinical psychologist; PhD

Leader for Section for clinical addiction research (www.rusforsk.no).

Affiliations:

1. Section for clinical addiction research, Department of mental health and addiction treatment, Oslo University Hospital
2. Department of psychology, University of Oslo

Research interests:

Clinical addiction research, treatment effect, psychotherapy research, personality disorder treatment

Relevant links:

Rusforsk research projects

Espen Ajo Arnevik - Google Scholar

Espen Ajo Arnevik - Orcid

 

Publications 2024

Høiland K, Arnevik EA, Egeland J (2024)
Alcohol use disorder and fitness to drive: Discrepancies between health professionals’ evaluations and objective measures of alcohol use and cognitive functioning
Nordic Studies on Alcohol and Drugs, 0, 1-13
DOI 10.1177/1455072523121997, PublikaID 481

Johannessen DA, Overå S, Arnevik EA (2024)
The role of contextual factors in avenues to recover from gambling disorder: a scoping review
Front Psychol, 15, 1247152
DOI 10.3389/fpsyg.2024.1247152, PubMed 38410405

Myklebust LH, Eide D, Arnevik EA, Dadras O, De Pirro S, Ellefsen R, Fadnes LT, Hesse M, Kvamme TL, Melis F, Oldervoll A, Thylstrup B, Wusthoff LEC, Clausen T (2024)
Evaluation of heroin-assisted treatment in Norway: protocol for a mixed methods study
BMC Health Serv Res, 24 (1), 398
DOI 10.1186/s12913-024-10767-w, PubMed 38553691

Publications 2023

Ellefsen R, Wüsthoff LEC, Arnevik EA (2023)
Patients' satisfaction with heroin-assisted treatment: a qualitative study
Harm Reduct J, 20 (1), 73
DOI 10.1186/s12954-023-00808-8, PubMed 37312181

Næss O, Ekeland TJ, Arnevik EA, Aarstad J, Lid TG (2023)
Governing by commissioning services - Implementing alcohol screening and brief interventions in hospital settings in Norway
Eval Program Plann, 98, 102271
DOI 10.1016/j.evalprogplan.2023.102271, PubMed 36921405

Rognli EB, Dalsrud MK, Wüsthoff LEC, Arnevik EA (2023)
[Poor uptake of service provision at a drug-related emergency department – a qualitative study]
Tidsskr Nor Laegeforen, 143 (5)
DOI 10.4045/tidsskr.22.0471, PubMed 36987889

Publications 2022

Bækkelund H, Ulvenes P, Boon-Langelaan S, Arnevik EA (2022)
Group treatment for complex dissociative disorders: a randomized clinical trial
BMC Psychiatry, 22 (1), 338
DOI 10.1186/s12888-022-03970-8, PubMed 35578194

Rognli EB, Støme LN, Kværner KJ, Wilhelmsen C, Arnevik EA (2022)
The effect of employment support integrated in substance use treatment: A health economic cost-effectiveness simulation of three different interventions
Nordisk Alkohol Nark, 40 (2), 199-211
DOI 10.1177/14550725221122196, PubMed 37063816

Zahl KE, Pedersen G, Eikenaes IU, Stänicke LI, Wilberg T, Baltzersen ÅL, Pettersen MS, Hummelen B, Arnevik E, Johansen MS, Hartveit Kvarstein E (2022)
Avoidant and borderline personality disorder patients during the first Covid-19 wave in Norway - a survey-based comparison of therapy changes and patients' accommodations
Nord J Psychiatry, 77 (4), 336-344
DOI 10.1080/08039488.2022.2110614, PubMed 35984379

Publications 2021

Bækkelund H, Karlsrud I, Hoffart A, Arnevik EA (2021)
Stabilizing group treatment for childhood-abuse related PTSD: a randomized controlled trial
Eur J Psychotraumatol, 12 (1), 1859079
DOI 10.1080/20008198.2020.1859079, PubMed 33537118

Kvarstein EH, Zahl KE, Stänicke LI, Pettersen MS, Baltzersen ÅL, Johansen MS, Eikenaes IU, Arnevik EA, Hummelen B, Wilberg T, Pedersen G (2021)
Vulnerability of personality disorder during the Covid-19 crises - a multicenter survey of treatment experiences among patients referred to treatment
Nord J Psychiatry, 76 (1), 52-63
DOI 10.1080/08039488.2021.1934110, PubMed 34126854

Rognli EB, Aas EM, Drake RE, Marsden J, Anders P, Bond GR, Lystad JU, Reme SE, Arnevik EA (2021)
The effect evaluation of Individual Placement and Support (IPS) for patients with substance use disorders: study protocol for a randomized controlled trial of IPS versus enhanced self-help
Trials, 22 (1), 705
DOI 10.1186/s13063-021-05673-z, PubMed 34654464

Publications 2020

Brorson HH, Arnevik EA, Rand-Hendriksen K, Duckert F (2020)
Corrigendum to "Drop-out from addiction treatment: A systematic review of risk factors"
Clin Psychol Rev, 76, 101796
DOI 10.1016/j.cpr.2019.101796, PubMed 32067823

Gatti F, Walderhaug E, Kern-Godal A, Lysell J, Arnevik EA (2020)
Complementary horse-assisted therapy for substance use disorders: a randomized controlled trial
Addict Sci Clin Pract, 15 (1), 7
DOI 10.1186/s13722-020-0183-z, PubMed 32019584

Paap MCS, Hummelen B, Braeken J, Arnevik EA, Walderhaug E, Wilberg T, Berghuis H, Hutsebaut J, Pedersen G (2020)
A multi-center psychometric evaluation of the Severity Indices of Personality Problems 118 (SIPP-118): Do we really need all those facets?
Qual Life Res, 30 (2), 567-575
DOI 10.1007/s11136-020-02654-8, PubMed 33029679

Rand K, Arnevik EA, Walderhaug E (2020)
Quality of life among patients seeking treatment for substance use disorder, as measured with the EQ-5D-3L
J Patient Rep Outcomes, 4 (1), 92
DOI 10.1186/s41687-020-00247-0, PubMed 33165764

Tonga JB, Eilertsen DE, Solem IKL, Arnevik EA, Korsnes MS, Ulstein ID (2020)
Effect of Self-Efficacy on Quality of Life in People With Mild Cognitive Impairment and Mild Dementia: The Mediating Roles of Depression and Anxiety
Am J Alzheimers Dis Other Demen, 35, 1533317519885264
DOI 10.1177/1533317519885264, PubMed 31916847

Tonga JB, Šaltytė Benth J, Arnevik EA, Werheid K, Korsnes MS, Ulstein ID (2020)
Managing depressive symptoms in people with mild cognitive impairment and mild dementia with a multicomponent psychotherapy intervention: a randomized controlled trial
Int Psychogeriatr, 33 (3), 217-231
DOI 10.1017/S1041610220000216, PubMed 32131911

Publications 2019

Arnevik EA, Pedersen G, Walderhaug E, Lien I, Wilberg T, Hummelen B (2019)
Measuring Personality Problems in Patients With Substance Use Disorders: A Cross-Sample Validation
J Dual Diagn, 15 (4), 324-332
DOI 10.1080/15504263.2019.1668583, PubMed 31571533

Brorson HH, Arnevik EA, Rand K (2019)
Predicting Dropout from Inpatient Substance Use Disorder Treatment: A Prospective Validation Study of the OQ-Analyst
Subst Abuse, 13, 1178221819866181
DOI 10.1177/1178221819866181, PubMed 31452601

Hauger LE, Sagoe D, Vaskinn A, Arnevik EA, Leknes S, Jørstad ML, Bjørnebekk A (2019)
Anabolic androgenic steroid dependence is associated with impaired emotion recognition
Psychopharmacology (Berl), 236 (9), 2667-2676
DOI 10.1007/s00213-019-05239-7, PubMed 30941469

Helverschou SB, Brunvold AR, Arnevik EA (2019)
Treating Patients With Co-occurring Autism Spectrum Disorder and Substance Use Disorder: A Clinical Explorative Study
Subst Abuse, 13, 1178221819843291
DOI 10.1177/1178221819843291, PubMed 31024216

Pedersen G, Arnevik EA, Hummelen B, Walderhaug E, Wilberg T (2019)
Psychometric Properties of the Severity Indices of Personality Problems (SIPP) in Two Samples A Norwegian Community Sample and Clinical Samples of Patients With and Without Personality Disorders
Eur. J. Psychol. Assess., 35 (5), 698-711
DOI 10.1027/1015-5759/a000436

Sømhovd M, Hagen E, Bergly T, Arnevik EA (2019)
The Montreal Cognitive Assessment as a predictor of dropout from residential substance use disorder treatment
Heliyon, 5 (3), e01282
DOI 10.1016/j.heliyon.2019.e01282, PubMed 31025003

Publications 2018

Bækkelund H, Frewen P, Lanius R, Ottesen Berg A, Arnevik EA (2018)
Trauma-related altered states of consciousness in post-traumatic stress disorder patients with or without comorbid dissociative disorders
Eur J Psychotraumatol, 9 (1), 1544025
DOI 10.1080/20008198.2018.1544025, PubMed 30455853

Hagen E, Sømhovd M, Hesse M, Arnevik EA, Erga AH (2018)
Measuring cognitive impairment in young adults with polysubstance use disorder with MoCA or BRIEF-A - The significance of psychiatric symptoms
J Subst Abuse Treat, 97, 21-27
DOI 10.1016/j.jsat.2018.11.010, PubMed 30577896

Publications 2016

Arnevik EA, Helverschou SB (2016)
Autism Spectrum Disorder and Co-occurring Substance Use Disorder - A Systematic Review
Subst Abuse, 10, 69-75
DOI 10.4137/SART.S39921, PubMed 27559296

Kern-Godal A, Brenna IH, Arnevik EA, Ravndal E (2016)
More Than Just a Break from Treatment: How Substance Use Disorder Patients Experience the Stable Environment in Horse-Assisted Therapy
Subst Abuse, 10, 99-108
DOI 10.4137/SART.S40475, PubMed 27746677

Kern-Godal A, Brenna IH, Kogstad N, Arnevik EA, Ravndal E (2016)
Contribution of the patient-horse relationship to substance use disorder treatment: Patients' experiences
Int J Qual Stud Health Well-being, 11, 31636
DOI 10.3402/qhw.v11.31636, PubMed 27291162

Lien IA, Arnevik EA (2016)
Assessment of personality problems among patients with substance use disorders
Nord. Stud. Alcohol Drugs, 33 (4), 399-414
DOI 10.1515/nsad-2016-0033

Nordheim K, Walderhaug E, Alstadius S, Kern-Godal A, Arnevik E, Duckert F (2016)
Young adults' reasons for dropout from residential substance use disorder treatment
Qual Soc Work, 17 (1), 24-40
DOI 10.1177/1473325016654559, PubMed 29276430

Publications 2015

Kern-Godal A, Arnevik EA, Walderhaug E, Ravndal E (2015)
Substance use disorder treatment retention and completion: a prospective study of horse-assisted therapy (HAT) for young adults
Addict Sci Clin Pract, 10, 21
DOI 10.1186/s13722-015-0043-4, PubMed 26466788

Tonga JB, Arnevik EA, Werheid K, Ulstein ID (2015)
Manual-based cognitive behavioral and cognitive rehabilitation therapy for young-onset dementia: a case report
Int Psychogeriatr, 28 (3), 519-22
DOI 10.1017/S1041610215001696, PubMed 26552831

Tonga JB, Karlsoeen BB, Arnevik EA, Werheid K, Korsnes MS, Ulstein ID (2015)
Challenges With Manual-Based Multimodal Psychotherapy for People With Alzheimer's Disease: A Case Study
Am J Alzheimers Dis Other Demen, 31 (4), 311-7
DOI 10.1177/1533317515603958, PubMed 26385947

Publications 2013

Amble I, Gude T, Stubdal S, Oktedalen T, Skjorten AM, Andersen BJ, Solbakken OA, Brorson HH, Arnevik E, Lambert MJ, Wampold BE (2013)
Psychometric properties of the outcome questionnaire-45.2: the Norwegian version in an international context
Psychother Res, 24 (4), 504-13
DOI 10.1080/10503307.2013.849016, PubMed 24188797

Kvarstein EH, Arnevik E, Halsteinli V, Rø FG, Karterud S, Wilberg T (2013)
Health service costs and clinical gains of psychotherapy for personality disorders: a randomized controlled trial of day-hospital-based step-down treatment versus outpatient treatment at a specialist practice
BMC Psychiatry, 13, 315
DOI 10.1186/1471-244X-13-315, PubMed 24268099

Publications 2010

Arnevik E, Wilberg T, Urnes Ø, Johansen M, Monsen JT, Karterud S (2010)
Psychotherapy for personality disorders: 18 months' follow-up of the ullevål personality project
J Pers Disord, 24 (2), 188-203
DOI 10.1521/pedi.2010.24.2.188, PubMed 20420475

Publications 2009

Arnevik E, Wilberg T, Monsen JT, Andrea H, Karterud S (2009)
A cross-national validity study of the Severity Indices of Personality Problems (SIPP-118)
Personal. Ment. Health, 3 (1), 41-55
DOI 10.1002/pmh.60

Publications 2008

Arnevik E, Wilberg T, Urnes O, Johansen M, Monsen JT, Karterud S (2008)
Psychotherapy for personality disorders: short-term day hospital psychotherapy versus outpatient individual therapy - a randomized controlled study
Eur Psychiatry, 24 (2), 71-8
DOI 10.1016/j.eurpsy.2008.09.004, PubMed 19097870